Clinical trial
Quantification of GADD34 Expression in Rheumatoid Arthritis
NCT02401165 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantification of GADD34 Expression in Rheumatoid Arthritis
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- May 31, 2014
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis